Who are we?

–

Founded in 2010, Orpyx® Medical Technologies empowers people with diabetes to maintain mobility. Orpyx’s core product line, the SurroSense Rx® system, helps prevent foot ulcers and limb loss through FDA cleared, advanced foot sensor technology and analytics, delivered in an easy-to use ultra-thin insole. Orpyx’s technology is used by researchers to access clinical-grade plantar pressure measurement data for health and human performance applications. Orpyx is focused on collaborating with stakeholders around the world to achieve a healthcare future that is prevention focused and sustainable in cost.

Why we’re here

–

Orpyx came into existence to help address a huge problem that medicine and surgery face on a daily basis — the problem of diabetes and complications of diabetes. Many of these problems stem from one of the main complications of diabetes, “peripheral neuropathy” (or, numb feet). Without feedback, people are unaware when damage is being done and complications develop.

Where we’re going

–

Orpyx looks to the next five years with the objective of becoming the world leader in innovating and developing wearable sensor-based technologies and sensory substitution systems that provide consumers with quality solutions to better cope with disease and improve overall quality of life.